propionate Crohn disease propionate active corticosteroid low systemic bioavailability oral administration pilot study treatment mild active Crohn disease patients oral fluticasone propionate weeks effects Crohn disease activity index granulocyte scanning inflammation scan appearances day faecal excretion radioactivity whole body excretion radioactivity patients trial serious side effects significant fall Crohn disease activity index values week treatment period leucocyte scan images patients unchanged patients significant fall excretion injected radioactivity whole body data changes plasma cortisol values basal synacthen propionate promising therapeutic agent Crohn disease possibility inflammation systemic corticosteroid side effects evaluation double blind trial conventional corticosteroids 